Citigroup Initiates Coverage On Catalyst Pharmaceuticals With Buy Rating, Announces Price Target of $27
Citigroup Initiates Coverage On Catalyst Pharmaceuticals With Buy Rating, Announces Price Target of $27
花旗集團以買入評級啓動對Catalyst Pharmicals的報道,宣佈目標股價爲27美元
Citigroup analyst Samantha Semenkow initiates coverage on Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Buy rating and announces Price Target of $27.
花旗集團分析師薩曼莎·塞門科以買入評級啓動了對Catalyst Pharmicals(納斯達克股票代碼:CPRX)的報道,並宣佈目標股價爲27美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。